Company Profile
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions. In addition, the company provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, vascular and cardiothoracic surgery equipment, peripheral stenting, OEM solutions, and beating heart surgery equipment; and operating room equipment, anesthesia, advanced patient monitoring, and operating room integration solutions. Further, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices, and patient flow management; and low temperature sterilization, biocontainment in vaccine production, terminal sterilization, sterile isolation technology, cleaning and sterilization, aseptic transfer, and large-scale cultivation. Additionally, the company provides bioreactor preparation solution, bioprocess development and optimization, labware cleaning and sterilization, biocontainment, and vivarium. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.
Latest News
Goldman Sachs leads oil and gas M&A advisory by value in H1 2026
Philippines' Marcos says 'perhaps time to revisit nuclear energy'
Camden National Bank Earnings: What To Look For From CAC
Black Book Expands Vendor-Agnostic Healthcare Supply Chain Technology Benchmark to 36 Categories for AHRMM26
Target Hospitality Announces New $660 Million Credit Facility, Significantly Expanding Liquidity and Lowering Cost of Capital to Support Strategic Growth
| Sector | Healthcare |
| Industry | Medical Devices |
| Website | https://www.getinge.com |
| Audit Risk | 10 |
| Board Risk | 9 |
| Overall Risk | 9 |
| Market Cap | 62.75B |
| Trailing P/E | 23.44 |
| Forward P/E | 21.06 |
| Dividend Rate | 4.75 |
| Dividend Yield | 2.06% |
| Trailing Annual Div. Rate | 4.75 |
| Trailing Annual Div. Yield | 2.06% |
| Trailing EPS | 9.83 |
| Forward EPS | 10.94 |
| Book Value | 113.61 |
| Price-to-Book | 2.03 |
| Enterprise-to-Revenue | 2.1 |
| Enterprise-to-EBITDA | 12.19 |
| Ex-Dividend Date | 04/22/2026 |
| Earnings Date | 10/21/2026 |
| Earnings Call Date | 07/17/2026 |
| Earnings Average | 3.04 |
| Earnings Low | 3.04 |
| Earnings High | 3.04 |
| Revenue Average | 8.37B |
| Revenue Low | 8.16B |
| Revenue High | 8.60B |